ADXN.SW
Addex Therapeutics Ltd
Price:  
0.06 
CHF
Volume:  
107,815.00
Switzerland | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ADXN.SW Probability of Bankruptcy

The Probability of Bankruptcy of Addex Therapeutics Ltd (ADXN.SW) is -% . This number represents the probability that ADXN.SW will face financial distress in the next 24 months given its current fundamentals and market conditions.

Multiple factors are taken into account when calculating ADXN.SW's probability of bankruptcy : Altman Z-score, Beneish M-score, financial position, macro environments, academic research about distress risk and more.

ADXN.SW - ESG ratings

ESG ratings are directly linked to the cost of capital and ADXN.SW's ability to raise funding, both of which can significantly affect the probability of Addex Therapeutics Ltd going bankrupt.

ESG Score 32.00
Environment Score 36.88
Social Score 18.03
Governance Score 41.09
Returns
Historical Returns (5 day) 3.57%
Historical Returns (MTD) -3.01%
Historical Returns (YTD) 1.40%
Historical Returns (13 week) -2.03%
Historical Returns (26 week) -30.29%
Historical Returns (52 week) -21.41%
Efficiency
Asset Turnover 0.04
Receiveable Turnover 5.25
Gross Margin
Operating Margin -842.72%
Pretax Margin -1,110.18%
Net Margin 912.38%
Return on Asset (ROA) 84.87
Return on Equity (ROE) 95.71
Return on Investments (ROI) 95.41
Price Metrics
Market Cap (M) 11.06
Enterprise Value (M)
52 Week High 0.11
52 Week Low 0.05
Beta 0.29
Average Volume (10 day) 0.20
Average Volume (3 month) 0.22
Price / Earnings (P/E) 2.05
Price / Sales (P/S) 18.67
Earnings
EPS 0.05
Revenue CAGR (5 year) -24.47%
Risk
Current Ratio 4.59
Quick Ratio 4.37